Cholangitis, Sclerosing
12
3
4
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.3%
1 terminated out of 12 trials
83.3%
-3.2% vs benchmark
8%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
Primary Sclerosing Cholangitis in Children
Swiss Primary Sclerosing Cholangitis Cohort Study
A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions
Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH
An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis
A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis